Letter to the Editor Regarding the Article "Use of Autologous Dendritic Cell Vaccine CaTeVac in Melanoma Patients: Final Results of the DENDRON-01 Study". (2026). Voprosy Onkologii, 72(1), OF-2542. https://doi.org/10.37469/0507-3758-2026-72-1-OF-2542